246 related articles for article (PubMed ID: 20810708)
1. Management of corticosteroid-induced osteoporosis.
Drug Ther Bull; 2010 Sep; 48(9):98-101. PubMed ID: 20810708
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids: no drug prevention of fractures needed.
Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
[TBL] [Abstract][Full Text] [Related]
3. Teriparatide: new indication. During corticosteroid therapy: no fewer clinical fractures. Unnecessarily inconvenient.
Prescrire Int; 2009 Aug; 18(102):159. PubMed ID: 19743573
[No Abstract] [Full Text] [Related]
4. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
Smith MD; Cheah SP; Taylor K; Ahern MJ
J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid osteoporosis: practical implications of recent trials.
Sambrook PN
J Bone Miner Res; 2000 Sep; 15(9):1645-9. PubMed ID: 10976984
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid induced osteoporosis. Guidelines for treatment.
Sambrook PN; Diamond T; Ferris L; Fiatarone-Singh M; Flicker L; MacLennan A; Nowson C; O'Neill S; Greville H; ;
Aust Fam Physician; 2001 Aug; 30(8):793-6. PubMed ID: 11681155
[TBL] [Abstract][Full Text] [Related]
7. Consultation corner. Bone loss drug gives users a break.
Bellantoni M
Johns Hopkins Med Lett Health After 50; 2007 Dec; 19(10):6. PubMed ID: 18225340
[No Abstract] [Full Text] [Related]
8. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
9. Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates.
Ringe JD; Farahmand P
Clin Rheumatol; 2007 Apr; 26(4):474-84. PubMed ID: 17122953
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid--once-yearly. Corticosteroid-induced osteoporosis: no benefit.
Prescrire Int; 2010 Apr; 19(106):63. PubMed ID: 20568485
[No Abstract] [Full Text] [Related]
11. [Osteoporosis].
Uelbelhart B; Rizzoli R
Rev Med Suisse; 2012 Jan; 8(324):109-10, 112-5. PubMed ID: 23185820
[TBL] [Abstract][Full Text] [Related]
12. [Prevention and treatment of corticosteroid-induced osteoporosis].
Uebelhart B; Rizzoli R
Rev Med Suisse Romande; 2000 Oct; 120(10):787-91. PubMed ID: 11109908
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study.
Reid DM; Hughes RA; Laan RF; Sacco-Gibson NA; Wenderoth DH; Adami S; Eusebio RA; Devogelaer JP
J Bone Miner Res; 2000 Jun; 15(6):1006-13. PubMed ID: 10841169
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid induced osteoporosis.
Sambrook PN
J Rheumatol Suppl; 1996 Aug; 45():19-22. PubMed ID: 8856647
[TBL] [Abstract][Full Text] [Related]
15. The effects of corticosteroids on bone growth and bone density.
Weldon D
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):3-11; quiz 11-3, 50. PubMed ID: 19663120
[TBL] [Abstract][Full Text] [Related]
16. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.
Buckley LM; Marquez M; Hudson JO; Downs RW; Vacek P; Small RE; Poses R
J Rheumatol; 1998 Nov; 25(11):2195-202. PubMed ID: 9818664
[TBL] [Abstract][Full Text] [Related]
17. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.
Amin S; LaValley MP; Simms RW; Felson DT
Arthritis Rheum; 1999 Aug; 42(8):1740-51. PubMed ID: 10446876
[TBL] [Abstract][Full Text] [Related]
18. How to manage osteoporosis in children.
Bianchi ML
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):991-1005. PubMed ID: 16301193
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid-induced osteoporosis.
Lucasey B
Nurs Clin North Am; 2001 Sep; 36(3):455-66, ix. PubMed ID: 11532660
[TBL] [Abstract][Full Text] [Related]
20. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
